How Will the Revised Annex 1 Impact Your Contamination Control Strategy

In this podcast episode, our guest is Marc García Gómez, a pharmaceutical contamination control strategy consultant. He is also the author of various articles in Spanish pharmaceutical magazines about cleaning and disinfection. During their talk, Marc discussed with Yan Kugel about the EU GMP Annex 1 Revision: Manufacture of Sterile Medicinal Products draft and how it would affect pharma companies and their current contamination strategies.
Here are some of the things you'll learn about listening to or watching the podcast:
· A new dawn for microbiologists in the pharmaceutical industry
· What critical ideas Annex one introduces
· What new roles will the Maintenance department, upper management, and operators will have
· The importance of validating aseptic agents
· How to start preparing for the Annex 1 launch
------------------------------------------------------------------------------------------------------
Watch or read the full podcast and read the article at https://podcast.qualistery.com/how-will-the-revised-annex-1-impact-your-contamination-control-strategy
------------------------------------------------------------------------------------------------------
This episode is Sponsored by Dot Compliance, the industry’s first ready-to-use Quality Management Solution powered by the SalesForce platform. Implementation of a new eQMS has never been quicker nor easier.
#Pharma #GMP #Pharmaceutical #Pharmaceuticalmanufacturing